Timing of Rehabilitation Following Cervical Spinal Surgery in Degenerative Myelopathy

June 4, 2026 updated by: University of Alberta

Feasibility of Early Post-operative Rehabilitation Following Cervical Spinal Surgery in Degenerative Myelopathy

The goal of this clinical trial is to learn whether starting rehabilitation earlier after surgery can improve recovery and is feasible and acceptable for adults with degenerative cervical myelopathy (DCM) undergoing cervical spine surgery. The main question it aims to answer is:

Does starting rehabilitation earlier improve walking, balance, physical activity, quality of life, and nervous system function after surgery?

Researchers will compare participants who begin rehabilitation two weeks after surgery with participants who begin rehabilitation six weeks after surgery to see if earlier rehabilitation leads to better recovery outcomes and participation.

Participants will:

Be randomly assigned to begin rehabilitation either two weeks or six weeks after surgery.

Attend physical therapy sessions twice per week for eight weeks focused on strength, balance, and walking.

Complete assessments of walking ability, balance, physical activity, quality of life, and nervous system function over several months after surgery.

Provide feedback about their experience with the rehabilitation program, including satisfaction and any side effects or challenges related to participation.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • adult (>18 years of age) with diagnosis of degenerative cervical myelopathy, within 2 weeks of spinal decompression surgery
  • plan to be discharged home from acute care (i.e., not admitted to another facility for post-operative rehabilitation)
  • able to stand with a maximum of one-person assist (+/- use of gait aid)
  • persistent functional impairment in lower extremity strength, balance, coordination, and/or gait
  • ability to attend an 8-week in-person rehabilitation program in Edmonton, Alberta

Exclusion Criteria:

  • discharge from acute care facility > 2 weeks post-operative
  • intra-operative or early post-operative complication delaying discharge or precluding participation in early rehabilitation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual Care Rehabilitation
Participants will begin post-operative rehabilitation 6 weeks following their cervical spine surgery
Active, task-specific physical therapy to enhance balance, walking, and strength
Experimental: Early Rehabilitation
Participants will begin post-operative rehabilitation 2 weeks following their cervical spine surgery
Active, task-specific physical therapy to enhance balance, walking, and strength

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in the Ten Metre Walk Test
Time Frame: Baseline and End Rehabilitation (8 weeks following Baseline)
Time to walk ten metres; lower times indicate faster walking speed
Baseline and End Rehabilitation (8 weeks following Baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in the Six Minute Walk Test
Time Frame: Baseline and End Rehabilitation (8 weeks following Baseline)
Distance walked in six minutes; longer distances indicate greater walking endurance
Baseline and End Rehabilitation (8 weeks following Baseline)
Change from Baseline in the Timed Up and Go
Time Frame: Baseline and End Rehabilitation (8 weeks following Baseline)
Time taken to stand, walk 3 metres and return to sitting position; longer time indicates balance and mobility impairments
Baseline and End Rehabilitation (8 weeks following Baseline)
Change from Baseline in the Berg Balance Scale
Time Frame: Baseline and End Rehabilitation (8 weeks following Baseline)
Standardized test that includes 14 balance tasks, with scores ranging from 0 to 56; lower scores indicate balance impairment
Baseline and End Rehabilitation (8 weeks following Baseline)
Change from Baseline on the 36-item Short Form Survey
Time Frame: Baseline and End Rehabilitation (8 weeks following Baseline)
Survey measuring health-related quality of life, with scores ranging from 0 to 100; higher scores indicate better health status
Baseline and End Rehabilitation (8 weeks following Baseline)
Change from Admission to Study on the modified Japanese Orthopaedic Association Scale
Time Frame: Study Admission and End of Study (12 weeks)
Score to evaluate the severity of degenerative cervical myelopathy, with scores ranging from 0 to 18; higher scores indicate more mild myelopathy
Study Admission and End of Study (12 weeks)
Change from Baseline in Motor-Evoked Potentials
Time Frame: Baseline and End Rehabilitation (8 weeks following Baseline)
Transcranial Magnetic Stimulation (TMS) will be used and electromyography (EMG) will be recorded in lower extremity muscles; size of motor-evoked potentials will be measured
Baseline and End Rehabilitation (8 weeks following Baseline)
Change from Baseline in Hoffman Reflexes
Time Frame: Baseline and End Rehabilitation (8 weeks following Baseline)
Hoffman reflexes will be elicited in the soleus muscle and electromyography (EMG) will be recorded; H:M ratios and rate-dependent depression will be measured.
Baseline and End Rehabilitation (8 weeks following Baseline)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility (Participant Recruitment and Retention)
Time Frame: From Study Admission to the End of Study (12 weeks)
The recruitment and drop out rates will be recorded
From Study Admission to the End of Study (12 weeks)
Acceptability
Time Frame: Immediately following rehabilitation (Week 8 for Intervention Group, Week 12 for Usual Care Control)
Participants will describe their satisfaction with the intervention (including content and timing) through a custom survey following the intervention
Immediately following rehabilitation (Week 8 for Intervention Group, Week 12 for Usual Care Control)
Safety (Adverse Events)
Time Frame: From Study Admission to the End of Study (12 weeks)
Details and timing of any adverse events will be documented for all participants
From Study Admission to the End of Study (12 weeks)
Change from Baseline in Daily Activity
Time Frame: Baseline and End Rehabilitation (8 weeks following Baseline)
Activity monitors will be used to measure daily activity levels (including step counts). Average activity over 4-7 days of monitoring will be calculated.
Baseline and End Rehabilitation (8 weeks following Baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 15, 2026

Primary Completion (Estimated)

October 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

May 27, 2026

First Submitted That Met QC Criteria

June 4, 2026

First Posted (Actual)

June 9, 2026

Study Record Updates

Last Update Posted (Actual)

June 9, 2026

Last Update Submitted That Met QC Criteria

June 4, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Myelopathy

Clinical Trials on Physical Therapy

Subscribe